ATE553770T1 - Masernvirus-nucleoprotein zur behandlung von atherosklerose - Google Patents

Masernvirus-nucleoprotein zur behandlung von atherosklerose

Info

Publication number
ATE553770T1
ATE553770T1 AT07821843T AT07821843T ATE553770T1 AT E553770 T1 ATE553770 T1 AT E553770T1 AT 07821843 T AT07821843 T AT 07821843T AT 07821843 T AT07821843 T AT 07821843T AT E553770 T1 ATE553770 T1 AT E553770T1
Authority
AT
Austria
Prior art keywords
atherosclerosis
treatment
measles virus
virus nucleoprotein
nucleoprotein
Prior art date
Application number
AT07821843T
Other languages
English (en)
Inventor
Ziad Mallat
Alain Tedgui
Branka Horvat
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE553770T1 publication Critical patent/ATE553770T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07821843T 2006-10-26 2007-10-25 Masernvirus-nucleoprotein zur behandlung von atherosklerose ATE553770T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291676A EP1916000A1 (de) 2006-10-26 2006-10-26 Verwendung von Masernvirus Nukleoprotein zur Atherosklerosebehandlung
PCT/EP2007/061480 WO2008049888A1 (en) 2006-10-26 2007-10-25 Use of measles virus nucleoprotein for treating atherosclerosis

Publications (1)

Publication Number Publication Date
ATE553770T1 true ATE553770T1 (de) 2012-05-15

Family

ID=37873096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07821843T ATE553770T1 (de) 2006-10-26 2007-10-25 Masernvirus-nucleoprotein zur behandlung von atherosklerose

Country Status (4)

Country Link
US (1) US20100256045A1 (de)
EP (2) EP1916000A1 (de)
AT (1) ATE553770T1 (de)
WO (1) WO2008049888A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2292260A1 (de) * 2009-08-13 2011-03-09 Institut Pasteur Verwendung des durch erweiterte Gefriertrocknung (EFD) abgetöteten Mycobakteriums bovis BCG zur Vorbeugung und Behandlung von Atherosklerose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1676602A1 (de) * 2005-01-04 2006-07-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Kontinuierlicheverabreichung von Epitope aus dem atherosklerotischem Belag zur Behandlung von Atheriosklerose
FR2885139B1 (fr) * 2005-04-29 2010-12-24 Agronomique Inst Nat Rech Preparation de complexes solubles proteine n-proteine p tronquee ou de proteine n soluble d'un virus de la famille des paramyxoviridae et leurs utilisations vaccinales

Also Published As

Publication number Publication date
US20100256045A1 (en) 2010-10-07
EP2083855B1 (de) 2012-04-18
EP1916000A1 (de) 2008-04-30
EP2083855A1 (de) 2009-08-05
WO2008049888A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
EA201071315A1 (ru) Ингибиторы протеазы вируса гепатита с
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
WO2007092622A3 (en) Compositions and methods for treating bone
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
ATE533774T1 (de) Neuartige nukleosidanaloge zur behandlung von virusinfektionen
EP2081593A4 (de) Bakterielle lebendimpfstoffe zur prophylaxe oder behandlung von virusinfektionen
DE602006010243D1 (de) 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen
NO20085243L (no) Farmasoytisk sammensetning til behandling av virusinfeksjoner og/eller tumorsykdommer gjennom inhibering av proteinfolding og Proteinnedbryting
EA201270656A1 (ru) Ингибиторы вируса гепатита с
EA200970916A1 (ru) Соединения 5,6-дигидро-1н-пиридин-2-она
EP1934025A4 (de) Zusammensetzung zur behandlung von holz, verfahren zur behandlung von holz und holzprodukt
EP2021352A4 (de) Behandlung von protein-missfaltung
WO2010053573A3 (en) Screen for inhibitors of filovirus and uses therefor
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
DE602008004317D1 (de) Verbindungen zur behandlung von hepatitis c
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE505473T1 (de) Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
WO2009114461A3 (en) Angiotensin (1-7) dosage forms and uses thereof
ATE555108T1 (de) Polyamide zur behandlung des menschlichen papilloma-virus
EP1905452A4 (de) Wirkstoff zur prävention oder behandlung von glaukomen
ATE532787T1 (de) Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus